HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis.

Abstract
Oxidative stress accelerates the pathogenesis of a number of chronic diseases including cancer growth and its metastasis. Transcription factor NF-E2-related factor-2 (Nrf2), which regulates the cellular defense system against oxidative stress, elicits essential protection against chemical-induced carcinogenic insults. We recently demonstrate that the systemic deletion of Nrf2 leads to an increased susceptibility to cancer metastasis, which is associated with aberrant reactive oxygen species (ROS) accumulation in myeloid-derived suppressor cells (MDSC). However, it remains elusive whether cellular antioxidant defense system in the myeloid lineage cells plays indispensable roles for metastatic cancer progression. We herein found that myeloid lineage-specific Nrf2-deficient mice exhibited an increased susceptibility to pulmonary metastasis of the mouse Lewis lung carcinoma cells, and ROS level was more highly elevated in MDSCs of cancer-bearing Nrf2-deficient mice. Similarly, myeloid lineage-specific deletion of selenocysteine-tRNA gene (Trsp), which is essential for synthesis of antioxidant selenoenzymes, resulted in increased number of metastatic nodules along with ROS accumulation in MDSCs of cancer-bearing mice. These results thus indicate that the antioxidant systems directed by Nrf2 and selenoenzymes contribute to the clearance of ROS in MDSCs, efficiently preventing cancer cell metastasis. Consistent with this notion, a synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole (CDDO-Im), a potent Nrf2 inducer, attenuated the ROS production in MDSCs, and thereafter reduced metastatic nodules. Taken together, this study provides compelling lines of evidence that Nrf2 inducer retains therapeutic efficacy against cancer cell metastasis.
AuthorsKeiichiro Hiramoto, Hironori Satoh, Takafumi Suzuki, Takashi Moriguchi, Jingbo Pi, Tooru Shimosegawa, Masayuki Yamamoto
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 7 Issue 8 Pg. 835-44 (Aug 2014) ISSN: 1940-6215 [Electronic] United States
PMID24866179 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2014 American Association for Cancer Research.
Chemical References
  • Antioxidants
  • Imidazoles
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • RNA, Transfer, Amino Acid-Specific
  • Reactive Oxygen Species
  • tRNA, selenocysteine-
  • imidazole
Topics
  • Animals
  • Antioxidants (metabolism)
  • Cell Line, Tumor
  • Cell Lineage
  • Gene Deletion
  • Imidazoles (chemistry)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Cells (cytology)
  • NF-E2-Related Factor 2 (genetics, metabolism)
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Neoplasms (metabolism, pathology)
  • Oxidative Stress
  • RNA, Transfer, Amino Acid-Specific (genetics, metabolism)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: